Takeda Pharmaceutical Co Ltd R&D Day - New York Transcript
(presentation)
Good afternoon, and welcome. It is my pleasure to welcome you all today to Takeda Pharmaceutical's R&D Day 2019. Along with all of us here in the room in New York, we are joined by a number of people by webcast. I'd like to thank you all for having joined us.
2019 has been a watershed year for Takeda. Today, we will share with you our plans for our near-term growth. We will share with you the confidence that we have in our long-term sustainable growth, and today, we will showcase how we are doing more for our patients worldwide.
I am Sheelagh Cawley-Knopf. I am Head of Global Portfolio Strategy and R&D, and I am your MC and your host for today's event.
Let me take a moment to walk you through today's event. I'd like to ask each of the speakers to stand up as I call your name. We will kick off shortly with welcoming -- with an overview of Takeda -- sorry, with Takeda by our President and CEO, Dr. Christophe Weber. We will then
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |